Private Equity’s Stealthy Vet Takeover Leaves Pet Owners Paying the Price
September 24, 2024 — In response to a joint Federal Trade Commission and Department of Justice Request for Information (RFI) on serial acquisitions and roll-up strategies across the economy, the American Economic Liberties Project submitted a comment last week detailing harmful corporate and private equity roll-ups in the veterinary industry and recommending robust enforcement.
New Economic Liberties White Paper Exposes Monopoly Abuse in Electric Utilities and Lays Out Roadmap to Cut Costs, Boost Innovation
September 26, 2024 — Amid growing recognition of the need to reform America’s electrical utility system to reduce consumer costs, improve reliability, and accelerate the transition to cleaner energy sources, the American Economic Liberties Project today released a new white paper, with contributors from the Massachusetts Institute of Technology (MIT), outlining policy recommendations to reform investor-owned utilities. The paper, “Reforming the Utility System to Better Serve the American Public,” is the third installment of Economic Liberties’ Industrial Policy and Competition Series.
DOJ Sues Visa for Weaponizing Dominance to Raise Costs On Everyday Americans and Small Businesses
September 24, 2024 — In response to news that the Department of Justice Antitrust Division has filed an antitrust suit against Visa for using its power to box out competitors and rival platforms from the debit payments market, imposing unfair price hikes on consumers and small businesses, the American Economic Liberties Project released the following statement.
FTC Cracks Down on Big Three PBMs for Rigging Insulin Prices Through Rebate Scheme
September 20, 2024 — In response to news that the Federal Trade Commission (FTC) has sued the “Big Three” pharmacy benefit managers (PBMs) and their affiliated group purchasing organizations (GPOs) for engaging in an allegedly illegal rebate scheme that inflated insulin list prices—boosting their own profits at the expense of vulnerable patients—the American Economic Liberties Project released the following statement.
Cigna’s Lawsuit Against the FTC Is Straight Out of the Monopolists Playbook
September 17, 2024 — In response to news that Cigna, owner of Express Scripts and one of the big three dominant pharmacy benefit managers (PBMs), has filed a defamation lawsuit against the Federal Trade Commission over its recent interim report from its 6(b) of the FTC Act investigation into the industry’s anticompetitive practices, the American Economic Liberties Project released the following statement.